Skip to content
Part 1 of our Year in Review video series is out now.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article September 2025 Psychedelic Patent Update

September 2025 Psychedelic Patent Update

  • Post published:October 20, 2025
  • Post category:Psychedelic Patent Analysis/Pα+
Read more about the article Psychedelic Funding Update: Q3 2025

Psychedelic Funding Update: Q3 2025

  • Post published:October 16, 2025
  • Post category:Analysis/Pα+
Read more about the article Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

  • Post published:October 14, 2025
  • Post category:Interviews/Pα+
Read more about the article The Psychedelic News Feed: October 6 – 12, 2025

The Psychedelic News Feed: October 6 – 12, 2025

  • Post published:October 13, 2025
  • Post category:Psychedelic News Feed Archive
Read more about the article Q2 2025: Oregon Psilocybin Services Update

Q2 2025: Oregon Psilocybin Services Update

  • Post published:October 10, 2025
  • Post category:Analysis/News/Pα+
Read more about the article The Psychedelic Practitioner: Issue 1

The Psychedelic Practitioner: Issue 1

  • Post published:October 9, 2025
  • Post category:News/The Psychedelic Practitioner
Read more about the article Psychedelic Investor Survey Q3 2025

Psychedelic Investor Survey Q3 2025

  • Post published:October 7, 2025
  • Post category:Analysis/News
Read more about the article The Psychedelic News Feed: Sept 29 – Oct 5, 2025

The Psychedelic News Feed: Sept 29 – Oct 5, 2025

  • Post published:October 6, 2025
  • Post category:Psychedelic News Feed Archive
Read more about the article Pα+ Psychedelic Bulletin #210: Compass Exec Defends Minimal Support Model in Stockholm; IV Ketamine Outperforms Esketamine Nasal Spray in Retrospective Study; Reunion Advances RE104 in Adjustment Disorder; Mindstate Wraps Phase I

Pα+ Psychedelic Bulletin #210: Compass Exec Defends Minimal Support Model in Stockholm; IV Ketamine Outperforms Esketamine Nasal Spray in Retrospective Study; Reunion Advances RE104 in Adjustment Disorder; Mindstate Wraps Phase I

  • Post published:October 3, 2025
  • Post category:Psychedelic Bulletin/Pα+
Read more about the article The Psychedelic News Feed: September 22 – 28, 2025

The Psychedelic News Feed: September 22 – 28, 2025

  • Post published:September 29, 2025
  • Post category:Psychedelic News Feed Archive

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More